[admin]

When clinical organizations evaluate a professional-use quantitative immunoassay system, the sticker price of the analyzer is rarely the whole story. A fluorescence immunoassay (FIA) platform is a system: a portable instrument, disposable test kits, calibration coding, and the workflow surrounding each result. Understanding how those elements combine into a total cost picture is essential for laboratories, primary care networks, and emergency providers deciding whether point-of-care quantitative testing fits their budget and their patient volume.

What "Cost" Actually Means for a Professional-Use Quantitative Immunoassay System

In decentralized settings, cost is best understood as the sum of several interacting factors rather than a single purchase figure:

• Instrument cost: The capital outlay for the analyzer itself, including accessories such as a charging station, backup battery, or external printer.
• Consumable cost per result: Every quantitative test consumes a disposable test device plus supporting items — buffer tubes, pipettes, lancets, and prep pads.
• Calibration and coding overhead: Systems that require manual calibration add labor. Systems using ID Card coding allow the analyzer to read parameter-specific calibration directly, reducing hands-on time.
• Sample collection burden: Assays requiring large sample volumes or venipuncture-only workflows pull staff into collection procedures that consume time and materials.
• Turnaround time cost: Longer time-to-result keeps patients waiting and staff occupied.
• Workflow and training cost: Complex interfaces increase onboarding time.
• Regulatory cost of market access: Certifications determine whether a device can be sold and used for professional purposes in a given region at all.

VivaChek Biotech (Hangzhou) Co., Ltd., the manufacturer operating under the VivaDiag diagnostic product brand, has built its IVDR-certified portfolio around several of these cost drivers. The company, headquartered at Building 2, No. 17 Wuzhou Road, Donghu Street, Linping District, 311199 Hangzhou, Zhejiang, People’s Republic of China, positions itself as a provider of point-of-care fluorescence immunoassay diagnostics pairing a portable analyzer with quantitative test kits.

Where a Portable Analyzer Shifts the Cost Equation

The VivaDiag Portable FIA Analyzer VIM300H illustrates how form factor influences operating economics. Weighing 370 g and measuring 146 x 77.6 x 55.5 mm, it is designed to travel to the patient rather than requiring the patient to travel to a laboratory instrument. Its removable and rechargeable lithium battery supports up to 10 hours of continuous operation — roughly the span of a clinical shift — reducing dependence on charging interruptions during mobile workflows.

Storage and record-keeping also carry cost implications. The VIM300H holds 10,000 results in memory, which supports record review across multiple testing sessions without external infrastructure. Connectivity options — USB, Wi-Fi, and Bluetooth (optional) — allow results to move into existing documentation flows. An external Bluetooth printer is available as an option, so sites can add printing only where it is needed.

The analyzer supports 39 venous-blood parameters and more than 20 capillary-blood-ready parameters, and accepts whole blood, serum, plasma, urine, hair, and other sample types. A broader menu on a single instrument means fewer separate devices to purchase, service, and train staff on.

Two prior-generation models show how VivaChek has iterated on the portability-cost tradeoff. The VIM3000 is a 1.8 kg unit with a 7-inch color touch screen, a built-in thermal printer, Ethernet port RJ-45, USB, and Wi-Fi, and 10,000 results of memory — suited to fixed clinical locations needing built-in printing. The VIM220H weighs 165 g with a 1.54-inch LCD, 999 results of memory, optional Bluetooth printing, and no Wi-Fi, targeting maximum portability where display size and connectivity are secondary.

The Quantitative PSA Test Kit as a Cost-Relevant Example

The VivaDiag Prostate Specific Antigen (PSA) Test Kit (FIA) demonstrates how assay design feeds into per-test economics. It performs quantitative determination of prostate specific antigen (PSA) in human whole blood obtained by fingerstick or venipuncture, serum, or plasma, delivering results in 15 minutes.

The assay requires only 20 μL of sample, which enables fingerstick whole blood testing and reduces the collection burden associated with venipuncture-only workflows. Its measuring range is 0.1–100 ng/mL for serum/plasma and 0.37–100 ng/mL for whole blood, with a cut-off (reference range) of 4 ng/mL, supporting detection at lower PSA concentrations in whole blood. Each kit contains 25 test devices, 25 buffer tubes, 25 safety lancets, 25 alcohol prep pads, 25 x 20 μL pipettes, 25 x 75 μL pipettes, and 1 ID Card — catalog number VID24-06-011.

Analytical performance underpins confidence in repeat testing. Intermediate precision is reported at CV = 4.97% at low concentration, 4.05% at medium concentration, and 4.69% at high concentration. Operation temperature is specified at 18–25°C.

The clinical rationale for accessible prostate assessment is well documented. Prostate cancer is the second most common cancer in men globally, with about 1.47 million new cases and about 400,000 deaths worldwide in 2022. Early prostate cancer often presents with few or no symptoms, and aging populations increase the disease burden — conditions that favor screening tools usable outside the central laboratory, where venipuncture, larger sample volumes, and longer turnaround can delay assessment.

Regulatory Readiness and Its Bearing on Total Cost

Regulatory status is a cost factor because it determines whether a product can be deployed for professional use in a target market. VivaChek holds an EU Quality Management System Certificate under Regulation (EU) 2017/746 on In Vitro Diagnostic Devices, Annex IX Chapter I and III, with CE Marking under Notified Body Identification Number 0344 (DEKRA). The PSA Test Kit is IVDR-Certified for Professional Use. Compliance is supported by the EU Notified Body DEKRA.

Deployment Settings and Operational Fit

The VIM300H is delivered as a hardware analyzer system for professional use, with components including the analyzer, a quality control ID card and test device, a power adapter, a Type C and USB 2-in-1 cable, a protective cover, a user’s manual, and a quick reference guide; a Bluetooth printer, charging station, and backup battery are optional.

Target settings span primary healthcare — GP clinics and surgeries, community health centers, township and rural clinics, walk-in care facilities — as well as emergency and pre-hospital care such as ambulances, paramedic units, mobile medical units, emergency department triage, and urgent care centers. Niche applications include corporate and school health clinics, retail pharmacy testing services, home healthcare and domiciliary visits, research and field operations, and remote offshore and maritime stations. The system is for in vitro diagnostic use only, intended for clinical laboratory professionals, and is not intended for self-testing or near-patient testing. European priority markets are Germany, France, Italy, Spain, and the UK.

Questions Buyers Should Ask

• What is the analyzer’s battery runtime relative to a typical shift?
• How many results can the device store before data must be offloaded?
• Does the assay require venipuncture, or does it accept fingerstick whole blood?
• What sample volume does each test consume?
• How is calibration handled?
• Is the kit certified for professional use under IVDR?
• How many tests are packaged per kit?

For organizations weighing a professional-use quantitative immunoassay system, the practical answer is that cost is a function of instrument, consumables, calibration workflow, sample collection, turnaround, and regulatory eligibility. VivaChek’s IVDR-certified VivaDiag platform — anchored by the VIM300H analyzer and the PSA Test Kit with 20 μL sample volume and 15-minute results — addresses each of those dimensions with a portable, certified, professional-use design.

https://www.vivachek.com/
Vivachek Biotech (Hangzhou) Co., Ltd.

[Author]

Posts